TI
NTRP

tru Independence’s Neurotrope, Inc. Common NTRP Stock Holding History

tru Independence’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,500
Closed -$2 – 945
2020
Q2 		$2 Hold
1,500
– – ﹤0.01% 835
2020
Q1 		$1 Hold
1,500
– – ﹤0.01% 716
2019
Q4 		$1K Buy
+1,500
New +$1.17K ﹤0.01% 919

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
PTP
Platform Technology Partners New York $519M AUM 20% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

tru Independence's NTRP Position: Q3 2020 in Review

tru Independence sold out of Neurotrope, Inc. Common (NTRP) in Q3 2020, closing a stake of 1,500 shares — an estimated $2 sold.

tru Independence first reported a position in NTRP in Q4 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 34 funds tracked by Wall St. Rank hold NTRP as of Q3 2020.

  • tru Independence reported no remaining Neurotrope, Inc. Common position as of Q3 2020 after selling out during the quarter.
  • tru Independence sold 1,500 Neurotrope, Inc. Common shares in Q3 2020, an estimated $2.
  • tru Independence first reported a position in Neurotrope, Inc. Common in Q4 2019 and held it in 3 quarters.
  • tru Independence's Neurotrope, Inc. Common position peaked at $1K in Q4 2019.
  • 34 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.